According to a 2009 report by the National Cancer Institute in the USA, the WT1 antigen ranked first among 75 common cancer antigens in an overall score of nine categories, including therapeutic efficacy, immunogenicity, cancer specificity, and expression [4]. Here, WT1 is linked to cancer.